- General information enquiries
- Call 00 800 6 7 8 9 10 11
- E-mail your questions

European Commission
Public Health
Accessibility tools
Service tools
Language selector
- Current languageen
Navigation path
- European Commission
- Public health
- Reference documents
- Register
- Orphan products
- Imetelstat sodium
Pharmaceuticals - Community Register
Community register of orphan medicinal products | GRANTED |
Product information |
Imetelstat sodium
| EU orphan designation number: | EU/3/15/1593
|
| Active ingredient: | Imetelstat sodium |
| Indication: | Treatment of myelofibrosis |
| Sponsor: | Janssen-Cilag International NV
Turnhoutseweg 30, B-2340 Beerse, België |
Public summary of scientific opinion
European Commission procedures |
| Close date procedure | Procedure type | EMEA number | Decision | summary publ | decision docs | annex |
| 16/12/2015 | Orphan designation | EMA/OD/154/15 | (2015)9515 of 14/12/2015 |


